March 12, 2024 /
NMO (NMOSD/Devics)
Click Image to listen to this video
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT
Categories
Latest Blog Posts
- Nasal MS therapy moves closer to results after final patient dosed
- Caregivers are like human assistive devices, but with feelings
- MS Takes a Toll on Caregivers, Too, Especially on Their Mental Health
- An MS caregiver’s dilemma: Do I stay or do I go?
- Variant tied to severe MS may affect cognition in healthy adults
- Trouble retrieving the right words with MS likely tied to cognition
- AI Reveals Hidden Gray Matter Lesions in Multiple Sclerosis
- 7 Self-Care Tips for Multiple Sclerosis
- MS Exercises for Better Balance and Coordination
- Improving access to NMOSD diagnosis: Multicenter evaluation of the iDOT AQP4 assay
- GLP-1 therapies and cognitive impairment: New data highlights possible “survival paradox”
- New research findings challenge old beliefs about myelin repair in MS
- FDA OKs first human trial of oral MS remyelination therapy PTD802
- Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU (European Union) as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses
- FDA clears CTA313 (Car-T Cellular Therapy) trial for progressive MS, autoimmune disease
- Multiple Sclerosis or Lupus: Can You Have Both?
- What to Know About the Link Between Multiple Sclerosis and Psoriatic Arthritis
- Is an MS Flare-Up the Same as a Relapse?
- Going Gluten-Free for MS? Here Are 5 Easy Recipes
- Blood Proteins Identified That Predict Multiple Sclerosis Early
